As of 2024-12-11, the Relative Valuation of Mirum Pharmaceuticals Inc (MIRM) is (24.69) USD. This relative valuation is based on P/E multiples. With the latest stock price at 44.10 USD, the upside of Mirum Pharmaceuticals Inc based on Relative Valuation is -156.0%.
The range of the Relative Valuation is (10.60) - (38.26) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 5.1x - 18.4x | 11.8x |
| Forward P/E multiples | 5.1x - 18.9x | 12.0x |
| Fair Price | (10.60) - (38.26) | (24.69) |
| Upside | -124.0% - -186.8% | -156.0% |
| Date | P/E |
| 2024-12-06 | -21.48 |
| 2024-12-05 | -21.35 |
| 2024-12-04 | -21.87 |
| 2024-12-03 | -21.92 |
| 2024-12-02 | -22.22 |
| 2024-11-29 | -22.23 |
| 2024-11-27 | -22.43 |
| 2024-11-26 | -21.71 |
| 2024-11-25 | -21.29 |
| 2024-11-22 | -21.51 |
| 2024-11-21 | -20.91 |
| 2024-11-20 | -21.01 |
| 2024-11-19 | -20.24 |
| 2024-11-18 | -19.92 |
| 2024-11-15 | -21.40 |
| 2024-11-14 | -22.25 |
| 2024-11-13 | -21.12 |
| 2024-11-12 | -20.33 |
| 2024-11-11 | -20.01 |
| 2024-11-08 | -20.20 |
| 2024-11-07 | -19.76 |
| 2024-11-06 | -19.76 |
| 2024-11-05 | -19.58 |
| 2024-11-04 | -19.45 |
| 2024-11-01 | -19.43 |
| 2024-10-31 | -18.50 |
| 2024-10-30 | -18.84 |
| 2024-10-29 | -18.78 |
| 2024-10-28 | -19.02 |
| 2024-10-25 | -18.70 |
| 2024-10-24 | -18.93 |
| 2024-10-23 | -18.48 |
| 2024-10-22 | -19.08 |
| 2024-10-21 | -18.92 |
| 2024-10-18 | -18.98 |
| 2024-10-17 | -18.91 |
| 2024-10-16 | -19.13 |
| 2024-10-15 | -19.10 |
| 2024-10-14 | -19.13 |
| 2024-10-11 | -19.29 |
| 2024-10-10 | -18.51 |
| 2024-10-09 | -18.20 |
| 2024-10-08 | -18.71 |
| 2024-10-07 | -18.64 |
| 2024-10-04 | -18.88 |
| 2024-10-03 | -19.05 |
| 2024-10-02 | -19.95 |
| 2024-10-01 | -19.29 |
| 2024-09-30 | -18.76 |
| 2024-09-27 | -18.68 |